Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphangioleiomyomatosis

S F Johnson1, D D Davey, M L Cibull

  • 1Department of Surgery, Chandler Medical Center, University of Kentucky, Lexington 40536-0084.

The American Surgeon
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Siblings of children with complex care needs: their perspectives and experiences of participating in everyday life.

Child: care, health and development·2016
Same author

The association between reading time and students' performance in a surgery clerkship.

Advances in health sciences education : theory and practice·2013
Same author

Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity.

International journal of obesity (2005)·2013
Same author

c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.

Oncogene·2011
Same author

PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types.

Cancer gene therapy·2008
Same author

Laparoscopic management of Meckel's diverticulum.

Current surgery·2005
Same journal

Complete Response of Merkel Cell Carcinoma to Immunotherapy and Single-Fraction Radiotherapy Following Severe COVID-19 Infection: A Case Report and Review of Immune Mechanism.

The American surgeon·2026
Same journal

Perioperative Acute Myocardial Infarction in Non-Cardiac Operations: A National Analysis.

The American surgeon·2026
Same journal

Outcomes of Completion Cholecystectomy: Association With Patient Comorbidity in a National Database.

The American surgeon·2026
Same journal

Building the Conversation: Editorial Stewardship in Contemporary Surgical Publishing.

The American surgeon·2026
Same journal

Musculoskeletal Pain in Surgeons on Operating Days.

The American surgeon·2026
Same journal

Splenectomy During Cytoreductive Surgery: Marker of Surgical Burden or Independent Predictor of Morbidity?

The American surgeon·2026
See all related articles

Lymphangiomyomatosis (LAM) is a rare, progressive lung disease in women of childbearing age. Early diagnosis is crucial as current treatments do not significantly improve survival rates for this condition.

Area of Science:

  • Pulmonary Medicine
  • Rare Diseases
  • Women's Health

Background:

  • Lymphangiomyomatosis (LAM) is a rare, progressive neoplastic disorder affecting women of childbearing potential.
  • It is characterized by abnormal smooth muscle cell proliferation.
  • LAM often presents diagnostic challenges, leading to delayed diagnosis and suboptimal management.

Observation:

  • Microscopic findings reveal smooth muscle proliferation obstructing airways, lymphatics, and vasculature.
  • Clinical manifestations include progressive dyspnea, recurrent pneumothorax, chylous effusions, and hemoptysis.
  • Despite various therapeutic approaches, patient survival rates remain poor, with most patients succumbing within a decade of diagnosis.

Findings:

  • This report details a case of LAM.

Related Experiment Videos

  • A comprehensive literature review on LAM is presented.
  • The study underscores the diagnostic difficulties and poor prognosis associated with LAM.

    • Implications:

    • Highlights the need for increased clinician awareness of LAM.
    • Emphasizes the importance of timely diagnosis for potentially improving patient outcomes.
    • Suggests a critical need for novel therapeutic strategies to enhance survival in LAM patients.